1. Combined polymer-curcumin conjugate and ependymal progenitor/stem cell treatment enhances spinal cord injury functional recovery
- Author
-
Richard M. England, Eric Lopez-Mocholi, Marta Cases-Villar, Ana Alastrue-Agudo, María J. Vicent, Raquel Requejo-Aguilar, and Victoria Moreno-Manzano
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Curcumin ,Polymers ,Biophysics ,Bioengineering ,Spinal cord injury ,Pharmacology ,Neuroprotection ,Biomaterials ,Rats, Sprague-Dawley ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Acetals ,Ependymal progenitor stem cells ,medicine ,Animals ,Rho kinase ,Progenitor cell ,Cells, Cultured ,Spinal Cord Injuries ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Polymer Therapeutics ,Recovery of Function ,medicine.disease ,Spinal cord ,Surgery ,Transplantation ,030104 developmental biology ,medicine.anatomical_structure ,Neuroprotective Agents ,chemistry ,Spinal Cord ,Mechanics of Materials ,Delayed-Action Preparations ,Ceramics and Composites ,Systemic administration ,Female ,Stem cell ,business ,030217 neurology & neurosurgery ,Stem Cell Transplantation - Abstract
Spinal cord injury (SCI) suffers from a lack of effective therapeutic strategies. Animal models of acute SCI have provided evidence that transplantation of ependymal stem/progenitor cells of the spinal cord (epSPCs) induces functional recovery, while systemic administration of the anti-inflammatory curcumin provides neuroprotection. However, functional recovery from chronic stage SCI requires additional enhancements in available therapeutic strategies. Herein, we report on a combination treatment for SCI using epSPCs and a pH-responsive polymer-curcumin conjugate. The incorporation of curcumin in a pH-responsive polymeric carrier mainchain, a polyacetal (PA), enhances blood bioavailability, stability, and provides a means for highly localized delivery. We find that PA-curcumin enhances neuroprotection, increases axonal growth, and can improve functional recovery in acute SCI. However, when combined with epSPCs, PA-curcumin also enhances functional recovery in a rodent model of chronic SCI. This suggests that combination therapy may be an exciting new therapeutic option for the treatment of chronic SCI in humans. (C) 2016 Elsevier Ltd. All rights reserved.
- Published
- 2016